Developed by scientists from AstraZeneca, Chalmers University of Technology & University of Gothenburg, DrugSIMS™ provides accurate determination of drug exposures at sub-cellular and organelle level enabling optimized efficiency of novel therapeutics. Click here or the button below to receive the whitepaper by email.